Our News

HKBU INPSIRE is a brand new youtube platform managed by Knowledge Transfer Office (KTO), to showcase HKBU’s innovation offers, KT impact, research excellence and commercialisation achievements. Over 80 high quality videos have been uploaded to this platform covering 5 main themes – Innovation, Society, Partnership, Research and Entrepreneurship.

Skin scars are the normal and inevitable outcome of wound healing. If a scar is not treated properly, it may turn into an elevated scar, or in more serious case, the elevated scar grows bigger and wider.

Chinese medicine skincare has been well-respected since ancient times. What is the magic behind it? In this article, we would like to share with you the entrepreneurial journey of a Scientist, Prof Zhang Hongjie – the Co-founder and Director of Gihon Biotech Limited (Gihon), who is also a Professor from School of Chinese Medicine at HKBU, on how he turned his research findings into a commercialised product and started his business in cosmetic application.

Hong Kong's film and television industry are a major influencer of global culture, and technological innovations have always been a key element in ensuring the competitiveness of such creative industries.

Aspiring to be a leading, research-led, liberal arts University in Asia, Hong Kong Baptist University is committed to conducting world-leading investigations that extends the frontiers of knowledge, tackles global challenges and benefits the community at home and abroad. 

Knowledge Transfer Partnership (KTP) is one of the engagement strategies for HKBU academics to commit in signature partnerships with the wider community. It involves collaboration between academics (e.g. professors and researchers), external partners (e.g. associations, NGOs), and the respective community being served. The collaboration projects enable the transfer of knowledge and research from HKBU to the community, empowering not only the external partners but also individual participants of the projects. The ultimate goal is to achieve far-reaching and significant research impact in the community.

In order to have a good protection of the IPRs of HKBU inventions within the constraint of limited funding resources of the respective academic unit, SPF has been established with the support of the Innovation and Technology Fund. This funding is available for those top quality first jurisdiction patent filings, which will be strategic if filed in a second or a third jurisdiction. The SPF provides grants of HK$30,000 each towards the costs of filing an approved patent in a second or third jurisdiction. This SPF funding can be used to match the $30,000 funding support from the University in paying for such patent applications.

HKBU TSSSU aims to bring R&D results from campus to real-world, by encouraging more entrepreneurial activities at the University and facilitating more commercial development of HKBU’s intellectual property rights (IPR) and technology developed at the University. It is a "company start-up" scheme designed to encourage spin-off companies to commercialise the IPR and technologies developed at HKBU.

The University is proactive in introducing new funding channels to facilitate knowledge transfer (KT) from academia to industry. The Matching Proof-of- Concept Fund (MPCF) is established to enhance knowledge transfer, particularly technology transfer, which is endorsed and valued by the University Grant Committee (UGC). Hong Kong Baptist University is providing additional funding to intellectual property creators at the University to establish proof of concept, identify a development path and an Intellectual Property Rights (IPR) strategy for innovative ideas arising from their research.

Are you aware of nanotechnology in your everyday life? For example, your glasses or swim goggles are anti-fog coated with nanoparticles for good vision. What’s more? A new product Mat A® Culture Nanomatrices by Mat-A-Cell Limited (“Mat-A-Cell”), which is a biological cell culture substrate coated with a self-developed nanolayer, can substantially reduce the risk of carcinogenesis or inflammation in stem cell therapy. In this article, you may get some inspiration and pragmatic tips for running a biotechnological startup from Mr Jefferson Lau Wai-fung, the CEO of Mat-A-Cell Limited, who is also an alumnus of Hong Kong Baptist University (HKBU).